alexa A Comparison of Post-treatment Quality of Life Outcomes for Endoluminal Brachytherapy and Chemoradiation for the Treatment of Localized Rectal Cancer
ISSN: 2471-2671

Archives of Surgical Oncology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

A Comparison of Post-treatment Quality of Life Outcomes for Endoluminal Brachytherapy and Chemoradiation for the Treatment of Localized Rectal Cancer

Azah A Althumairi1, Francesca Monn1, Joseph M Herman2, Amol K Narang2, Amy Hacker-Prietz2, Jonathan E Efron1, Elizabeth C Wick1 and Susan L Gearhart1*

1Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA

2Department of Radiation Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

*Corresponding Author:
Susan L Gearhart, M.D
600 N. Wolfe Street, Blalock 618
Baltimore, MD 21287, USA
Tel: 410-955-7323
Fax: 410-614-9866
E-mail: [email protected]

Received date: February 12, 2016; Accepted date: March 26, 2016; Published date: March 31, 2016

Citation: Althumairi AA, Monn F, Herman JM, Narang AK, Hacker-Prietz A, et al. (2016) A Comparison of Post-treatment Quality of Life Outcomes for Endoluminal Brachytherapy and Chemoradiation for the Treatment of Localized Rectal Cancer. Arch Surg Oncol 2:112. doi:10.4172/2471-2671.1000112

Copyright: © 2016 Althumairi AA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Summary: The current study showed that short four day course endoluminal brachytherapy is an effective neoadjuvant treatment for locally advanced rectal cancer; however, it was associated with worsening post-treatment global quality of life and more gastrointestinal symptoms following treatment.

Purpose: An attractive alternative to long course neoadjuvant chemoradiation (CRT) for rectal adenocarcinoma is short four day course endoluminal brachytherapy (EBT). However, quality of life (QOL) following EBT is unknown. We aim to compare post-treatment QOL between EBT and CRT.

Methods: 17 patients with localized rectal cancer were prospectively enrolled on a pilot study of EBT. For comparison, prospectively collected QOL for 50 patients received CRT for rectal adenocarcinoma was included. QOL was measured using European Organization for Research and Treatment of Cancer (EORTC QLQ-C30 and EORTC QLQ-CR29) given to patients prior to, during, and at 3 – 6 weeks following treatment.

Results: Comparing baseline mean scores to 3 – 6 weeks following EBT treatment, patients at the end of EBT had lower means scores in global functioning (81.0 vs. 53.0, p < 0.01); role functioning (90.0 vs. 63.0, p < 0.01); social functioning (91.0 vs. 68.0, p < 0.01); increased anxiety (89.0 vs. 62.0, p < 0.01); higher scores for pain (11.0 vs. 46.9, p < 0.01); fatigue (19.3 vs. 46.2, p < 0.01); and buttock pain (17.0 vs. 62.0, p < 0.01). Compared to mean difference of scores from baseline to the end of treatment for the control group, patients undergoing EBT had worsening global functioning (28.0 vs. 0, p < 0.01); physical functioning (12.2 vs. 2.0, p < 0.01); role functioning (27.1 vs. 3.3, p < 0.01); social functioning (23.4 vs. 1.0, p < 0.01); changes in weight (28.3 vs. 1.0, p < 0.01); higher scores for pain (35.8 vs. 6.7, p < 0.01); fatigue (26.9 vs. 1.2, p < 0.01); dysuria (17.9 vs. 5.3, p < 0.01); abdominal pain (27.2 vs. 2.8, p < 0.01); and buttock pain (45.6 vs. 8.0, p < 0.01).

Conclusion: Although EBT is an effective alternative, rectal cancer patients may experience worse acute preoperative global QOL and more gastrointestinal symptoms following treatment. Efforts should be made to minimize these symptoms during treatment. Further studies are needed to determine the long-term effects of EBT on QOL.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords